查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1955095

全球肺功能检测系统市场：市场规模、占有率、成长率、行业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034 年）

Pulmonary Function Testing Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 108 Pages | 商品交期: 请询问到货日

价格

肺功能检测 (PFT) 系统市场成长驱动因子

由于慢性呼吸系统疾病盛行率的上升以及诊断设备的技术进步，预计全球肺功能检测 (PFT) 系统市场在预测期内将稳定成长。肺功能检测系统是用于执行各种呼吸评估的专用仪器，包括肺活量测定、肺容量测量、肺容积描记法、弥散能力测量和氮气清除试验。 这些系统对于诊断和治疗气喘、慢性阻塞性肺病 (COPD) 和肺癌等呼吸道疾病至关重要。

市场规模及预测

2025年全球肺功能检测系统市场规模为1.712亿美元，预计2026年将成长至1.7868亿美元。 预计到2034年，该市场规模将达到2.6138亿美元，2026年至2034年的复合年增长率 (CAGR) 为4.87%。 2025年，北美以41.60%的市占率领先，其中美国占主导地位。在美国，人们对早期诊断意识的提高以及肺功能检测系统的不断进步正在推动市场成长。预计到2032年，光是美国市场规模就将达到9,010万美元，反映出全片幅和便携式肺功能检测系统均呈现强劲的普及趋势。

市场驱动因素

肺功能检测系统市场成长的主要驱动因素如下：

  • 发展中地区呼吸道疾病（尤其是慢性阻塞性肺病、气喘和职业性肺病）盛行率不断上升。根据2022年全球气喘报告，印度约有3,500万人患有气喘，凸显了早期诊断和监测的迫切性。
  • 医护人员和病人对早期诊断的认识不断提高。肺功能检测系统能够及早发现无症状个体的肺功能障碍，以达到及时治疗。
  • 技术进步，包括便携式肺功能检测系统。这些系统在诊所和分散式医疗机构的应用日益广泛。

新冠疫情的影响

由于医疗机构准入限制以及对检测过程中病毒传播的担忧，新冠疫情暂时阻碍了市场发展。 根据加拿大胸腔科协会 (CTS) 的说法，肺功能测试已恢復，但仅限于 COVID-19 检测结果为阴性的患者。疫情过后，市场于 2022 年开始復苏，随着正常营运的恢復，需求稳定成长。

市场限制因子

儘管市场成长，仍面临以下挑战：

  • 交叉感染风险：肺功能测试使用口含器、阀门和导管，这些设备可能传播结核病等传染病。
  • 熟练医护人员短缺，尤其是在开发中国家。例如，在印度，受过训练的医护人员数量低于每万人 22.8 人的建议标准，限制了肺功能测试的有效实施。

市场区隔

依类型：

  • 到 2026 年，完整系统将主导市场，达到 1.0547 亿美元，市场占有率达 59.03%，这主要得益于医院采用该系统进行全面的呼吸系统评估。
  • 由于诊所和独立诊断中心使用量的增加，以及人们对空气污染日益关注，便携式系统预计将实现最快增长。

依最终用户：

  • 到 2026 年，医院将占最大市场占有率，达到 9,532 万美元（53.35%）。这主要归因于人口老化加剧以及寻求治疗的气喘和慢性阻塞性肺病 (COPD) 患者数量增加。
  • 由于便携式系统的普及，预计医生集团将以最高的复合年增长率成长。
  • 此外，由于人们对肺部健康的认识不断提高以及早期诊断的努力，咨询和诊断中心发挥着至关重要的作用。

区域洞察

  • 北美市场预计将在2025年以7,117万美元的规模引领市场，主要得益于肺功能检测（PFT）系统的高普及率以及呼吸系统疾病的增加。预计到2026年，美国市场规模将达到6,850万美元。
  • 在欧洲，医疗基础设施的改善以及慢性阻塞性肺病（COPD）和气喘患者的增加是推动市场发展的利多因素，预计到2026年，英国市场规模将达到700万美元，德国将达到1120万美元。
  • 由于宣传活动的开展和医疗基础设施的改善，亚太地区预计将拥有最高的复合年增长率（CAGR）。预计2026年，日本市场规模将达到1,150万美元，中国将达到1,450万美元，印度将达到500万美元。 由于医疗基础设施投资增加以及肺功能检测需求不断增长，拉丁美洲和中东及非洲地区正经历稳定成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要产业趋势：併购、商业联盟等
  • 气喘和慢性阻塞性肺病发病率和盛行率：依主要国家和地区划分（2025 年）
  • 定价：依主要产品/主要公司划分（2025 年）
  • 新冠疫情的影响市场

第五章 全球肺功能测试系统市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 便携式
    • 全功能型
  • 市场分析、洞察与预测：依最终用户划分
    • 医院
    • 咨询（诊断）中心
    • 医生集团（诊所）
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美肺功能测试系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲肺功能测试系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章 亚太地区肺功能测试系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 其他亚洲国家太平洋

第九章 拉丁美洲肺功能侦测系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家/地区

第十章 中东与非洲肺功能检测系统市场分析：洞察与预测（2021-2034）

  • 国家细分
    • 南非
    • 海湾合作委员会
    • 其他中东和非洲国家/地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • ndd Medizintechnik AG
    • COSMED srl
    • MGC Diagnostics Corporation
    • Morgan Scientific
    • CHEST M.I., Inc.
    • VYAIRE MEDICAL, INC.
    • KoKo PFT
    • Medical Electronic Construction
Product Code: FBI101158

Growth Factors of pulmonary function testing (PFT) system Market

The global pulmonary function testing (PFT) system market is projected to grow steadily over the forecast period due to the rising prevalence of chronic respiratory diseases and technological advancements in diagnostic devices. Pulmonary function testing systems are specialized devices used to perform various respiratory assessments, including spirometry, lung volumes, plethysmography, diffusion capacity, and nitrogen washout tests. These systems are critical in diagnosing and managing respiratory disorders such as asthma, COPD, and lung cancer.

Market Size & Forecast

The global pulmonary function testing system market was valued at USD 171.2 million in 2025, expected to grow to USD 178.68 million in 2026, and is projected to reach USD 261.38 million by 2034, with a CAGR of 4.87% from 2026 to 2034. North America dominated the market in 2025 with a 41.60% share, led by the U.S., where rising awareness about early diagnosis and continuous advancements in PFT systems drive market growth. The U.S. market alone is projected to reach USD 90.1 million by 2032, reflecting strong adoption of both complete and portable PFT systems.

Market Drivers

The growth of the PFT system market is primarily driven by:

  • Increasing prevalence of respiratory diseases, such as COPD, asthma, and occupational lung disorders, particularly in developing regions. According to the Global Asthma Report 2022, approximately 35 million people in India suffer from asthma, highlighting the urgent need for early diagnosis and monitoring.
  • Rising awareness of early diagnosis among healthcare providers and patients. PFT systems allow early detection of lung dysfunction in asymptomatic individuals, enabling timely treatment.
  • Technological advancements including portable PFT systems, which are increasingly used in clinics and decentralized healthcare facilities.

COVID-19 Impact

The COVID-19 pandemic temporarily hindered the market due to limited access to healthcare facilities and concerns about virus transmission during testing. According to the Canadian Thoracic Society (CTS), pulmonary function tests resumed only for patients with negative COVID-19 status. Post-pandemic, market recovery began in 2022, with demand steadily increasing as normal operations resumed.

Market Restraints

Despite growth, the market faces challenges, including:

  • Risk of cross-contamination, as PFT procedures involve mouthpieces, valves, and tubing, which can transmit infections like tuberculosis.
  • Shortage of skilled healthcare professionals, especially in developing countries. For instance, in India, the trained healthcare workforce falls below the recommended 22.8 skilled workers per 10,000 population, limiting effective adoption.

Market Segmentation

By Type:

  • Complete systems dominated the market in 2026, reaching USD 105.47 million with a 59.03% share, driven by hospital adoption for comprehensive respiratory assessments.
  • Portable systems are expected to exhibit the fastest growth due to increased use in clinics, independent diagnostic centers, and rising air pollution concerns.

By End-User:

  • Hospitals held the largest share in 2026 at USD 95.32 million (53.35%), fueled by the growing geriatric population and increased patient visits for asthma and COPD.
  • Physician clinics are projected to grow at the highest CAGR, supported by the adoption of portable systems.
  • Physical examination/diagnostic centers also play a crucial role due to increased awareness of lung health and early diagnosis initiatives.

Regional Insights

  • North America led the market with a valuation of USD 71.17 million in 2025, driven by high adoption of PFT systems and a growing prevalence of respiratory diseases. The U.S. market is projected at USD 68.5 million by 2026.
  • Europe benefits from improved healthcare infrastructure and rising cases of COPD and asthma, with the UK at USD 7 million and Germany at USD 11.2 million by 2026.
  • Asia Pacific is expected to witness the highest CAGR, propelled by awareness campaigns and healthcare infrastructure improvements. The Japan market is projected at USD 11.5 million, China at USD 14.5 million, and India at USD 5 million by 2026.
  • Latin America and Middle East & Africa are growing steadily due to investments in healthcare infrastructure and rising demand for lung function testing.

Competitive Landscape

The market is consolidated with major players such as VYAIRE MEDICAL, INC., MGC Diagnostics Corporation, PulmOne Advanced Medical Devices, ndd Medizintechnik AG, KoKo PFT, and CHEST M.I., Inc.. Companies are focusing on product launches, partnerships, and geographic expansion. Key developments include:

  • March 2023: Vitalograph launched the VitaloPFT Pulmonary Function Testing Series and partnered with Morgan Scientific to integrate advanced software with hardware.
  • January 2023: CAIRE Inc. acquired MGC Diagnostics Corporation to strengthen its pulmonary disease expertise.

Market Trends

  • Shift from complete to portable systems in clinics and decentralized healthcare settings.
  • Rising adoption of PFT systems for early diagnosis and preventive care.
  • Increasing investments by healthcare providers in technologically advanced diagnostic systems.

Conclusion

The global pulmonary function testing system market is projected to grow from USD 171.2 million in 2025 to USD 261.38 million by 2034, driven by increasing prevalence of chronic respiratory diseases, advancements in portable and complete systems, and rising awareness of early diagnosis. North America dominates the market, while Asia Pacific is emerging as the fastest-growing region. The market presents opportunities for key players through innovation, expansion into developing countries, and partnerships with healthcare providers.

Segmentation By Type

  • Portable
  • Complete

By End-user

  • Hospitals
  • Physical Examination (Diagnostic) Centers
  • Physician Groups (Clinics)
  • Others

By Region

  • North America (By Type, By End-user, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By End-user, By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Type, By End-user, By Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, By End-user, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By End-user, By Country/Sub-region)
    • South Africa
    • GCC
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments (Mergers, Acquisitions, Partnerships)
  • 4.2. Incidence and Prevalence of Asthma and COPD, Key Countries/ Region, 2025
  • 4.3. Pricing, Key Products / Key Players, 2025
  • 4.4. Impact of COVID-19 on the Market

5. Global Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Portable
    • 5.1.2. Complete
  • 5.2. Market Analysis, Insights and Forecast - By End-user
    • 5.2.1. Hospitals
    • 5.2.2. Physical Examination (Diagnostic) Centers
    • 5.2.3. Physician Groups (Clinics)
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Portable
    • 6.1.2. Complete
  • 6.2. Market Analysis, Insights and Forecast - By End-user
    • 6.2.1. Hospitals
    • 6.2.2. Physical Examination (Diagnostic) Centers
    • 6.2.3. Physician Groups (Clinics)
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Portable
    • 7.1.2. Complete
  • 7.2. Market Analysis, Insights and Forecast - By End-user
    • 7.2.1. Hospitals
    • 7.2.2. Physical Examination (Diagnostic) Centers
    • 7.2.3. Physician Groups (Clinics)
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Rest of Europe

8. Asia Pacific Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Portable
    • 8.1.2. Complete
  • 8.2. Market Analysis, Insights and Forecast - By End-user
    • 8.2.1. Hospitals
    • 8.2.2. Physical Examination (Diagnostic) Centers
    • 8.2.3. Physician Groups (Clinics)
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Rest of Asia Pacific

9. Latin America Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Portable
    • 9.1.2. Complete
  • 9.2. Market Analysis, Insights and Forecast - By End-user
    • 9.2.1. Hospitals
    • 9.2.2. Physical Examination (Diagnostic) Centers
    • 9.2.3. Physician Groups (Clinics)
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Pulmonary Function Testing System Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Portable
    • 10.1.2. Complete
  • 10.2. Market Analysis, Insights and Forecast - By End-user
    • 10.2.1. Hospitals
    • 10.2.2. Physical Examination (Diagnostic) Centers
    • 10.2.3. Physician Groups (Clinics)
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. South Africa
    • 10.3.2. GCC
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. ndd Medizintechnik AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. COSMED srl
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. MGC Diagnostics Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Morgan Scientific
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. CHEST M.I., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. VYAIRE MEDICAL, INC.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. KoKo PFT
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medical Electronic Construction
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 2: Global Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 3: Global Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 4: North America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 5: North America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 6: North America Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 7: Europe Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 8: Europe Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 9: Europe Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Asia Pacific Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 14: Latin America Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 15: Latin America Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Pulmonary Function Testing System Market Revenue (USD million) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Pulmonary Function Testing System Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 18: Middle East & Africa Pulmonary Function Testing System Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Pulmonary Function Testing System Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Pulmonary Function Testing System Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Pulmonary Function Testing System Market Value Share (%), by End-user, 2025 & 2034
  • Figure 4: Global Pulmonary Function Testing System Market Value (USD million), by Region, 2025 & 2034
  • Figure 5: North America Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 6: North America Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 7: North America Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 8: North America Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 9: North America Pulmonary Function Testing System Market Value (USD million), By Country, 2025 & 2034
  • Figure 10: North America Pulmonary Function Testing System Market Value Share (%), By Country, 2025
  • Figure 11: Europe Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 12: Europe Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 13: Europe Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 14: Europe Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 15: Europe Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 18: Asia Pacific Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 19: Asia Pacific Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 20: Asia Pacific Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 21: Asia Pacific Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 24: Latin America Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 25: Latin America Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 26: Latin America Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 27: Latin America Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Pulmonary Function Testing System Market Value (USD million), by Type, 2025 & 2034
  • Figure 30: Middle East & Africa Pulmonary Function Testing System Market Value Share (%), by Type, 2025
  • Figure 31: Middle East & Africa Pulmonary Function Testing System Market Value (USD million), by End-user, 2025 & 2034
  • Figure 32: Middle East & Africa Pulmonary Function Testing System Market Value Share (%), by End-user, 2025
  • Figure 33: Middle East & Africa Pulmonary Function Testing System Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Pulmonary Function Testing System Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Pulmonary Function Testing System Market Share (%), By Company, 2025